138 related articles for article (PubMed ID: 9197522)
21. [Alterations of DPC4/SMAD4/MADH4 gene detected in paraffin-embedded tissues of human pancreatic carcinomas].
Gu LJ; Chen J; Liu TH; Cui QC; Lu ZH; Li L; Gao J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):165-9. PubMed ID: 12905795
[TBL] [Abstract][Full Text] [Related]
22. Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.
Papadimitrakopoulou VA; Oh Y; El-Naggar A; Izzo J; Clayman G; Mao L
Clin Cancer Res; 1998 Mar; 4(3):539-44. PubMed ID: 9533520
[TBL] [Abstract][Full Text] [Related]
23. DPC4/Smad4: no mutations, rare allelic imbalances, and retained protein expression in pancreatic endocrine tumors.
Perren A; Saremaslani P; Schmid S; Bonvin C; Locher T; Roth J; Heitz PU; Komminoth P
Diagn Mol Pathol; 2003 Dec; 12(4):181-6. PubMed ID: 14639103
[TBL] [Abstract][Full Text] [Related]
24. Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.
Hua Z; Zhang YC; Hu XM; Jia ZG
World J Gastroenterol; 2003 Dec; 9(12):2764-7. PubMed ID: 14669329
[TBL] [Abstract][Full Text] [Related]
25. Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.
Lassus H; Salovaara R; Aaltonen LA; Butzow R
Am J Pathol; 2001 Jul; 159(1):35-42. PubMed ID: 11438451
[TBL] [Abstract][Full Text] [Related]
26. Allelic imbalance in chromosome band 18q21 and SMAD4 mutations in ovarian cancers.
Takakura S; Okamoto A; Saito M; Yasuhara T; Shinozaki H; Isonishi S; Yoshimura T; Ohtake Y; Ochiai K; Tanaka T
Genes Chromosomes Cancer; 1999 Mar; 24(3):264-71. PubMed ID: 10451707
[TBL] [Abstract][Full Text] [Related]
27. Transfer of chromosome 18 into human head and neck squamous carcinoma cells: evidence for tumor suppression by Smad4/DPC4.
Reiss M; Santoro V; de Jonge RR; Vellucci VF
Cell Growth Differ; 1997 Apr; 8(4):407-15. PubMed ID: 9101086
[TBL] [Abstract][Full Text] [Related]
28. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers.
Nagatake M; Takagi Y; Osada H; Uchida K; Mitsudomi T; Saji S; Shimokata K; Takahashi T; Takahashi T
Cancer Res; 1996 Jun; 56(12):2718-20. PubMed ID: 8665501
[TBL] [Abstract][Full Text] [Related]
29. Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms.
Lei J; Zou TT; Shi YQ; Zhou X; Smolinski KN; Yin J; Souza RF; Appel R; Wang S; Cymes K; Chan O; Abraham JM; Harpaz N; Meltzer SJ
Oncogene; 1996 Dec; 13(11):2459-62. PubMed ID: 8957088
[TBL] [Abstract][Full Text] [Related]
30. Germline mutations of the dpc4 gene in Korean juvenile polyposis patients.
Kim IJ; Ku JL; Yoon KA; Heo SC; Jeong SY; Choi HS; Hong KH; Yang SK; Park JG
Int J Cancer; 2000 May; 86(4):529-32. PubMed ID: 10797267
[TBL] [Abstract][Full Text] [Related]
31. [Detection of alterations of the DPC4 gene in paraffin-embedded tissues of pancreatic carcinomas].
Gu L; Cui Q; Chen J; Li L; Liu T
Zhonghua Bing Li Xue Za Zhi; 2000 Aug; 29(4):256-8. PubMed ID: 11866919
[TBL] [Abstract][Full Text] [Related]
32. Molecular analyses of the 15q and 18q SMAD genes in pancreatic cancer.
Jonson T; Gorunova L; Dawiskiba S; Andrén-Sandberg A; Stenman G; ten Dijke P; Johansson B; Höglund M
Genes Chromosomes Cancer; 1999 Jan; 24(1):62-71. PubMed ID: 9892110
[TBL] [Abstract][Full Text] [Related]
33. Somatic alterations of the DPC4 and Madr2 genes in colorectal cancers and relationship to metastasis.
Ohtaki N; Yamaguchi A; Goi T; Fukaya T; Takeuchi K; Katayama K; Hirose K; Urano T
Int J Oncol; 2001 Feb; 18(2):265-70. PubMed ID: 11172591
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.
Wilentz RE; Su GH; Dai JL; Sparks AB; Argani P; Sohn TA; Yeo CJ; Kern SE; Hruban RH
Am J Pathol; 2000 Jan; 156(1):37-43. PubMed ID: 10623651
[TBL] [Abstract][Full Text] [Related]
35. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis.
Lüttges J; Galehdari H; Bröcker V; Schwarte-Waldhoff I; Henne-Bruns D; Klöppel G; Schmiegel W; Hahn SA
Am J Pathol; 2001 May; 158(5):1677-83. PubMed ID: 11337365
[TBL] [Abstract][Full Text] [Related]
36. Rare alteration of genomic structure or expression of the DPC4 gene in myelogenous leukemias.
Kaneko H; Horiike S; Sasai Y; Iwai T; Nakao M; Yokota S; Taniwaki M; Kashima K; Misawa S
Acta Haematol; 1998; 99(4):187-90. PubMed ID: 9644295
[TBL] [Abstract][Full Text] [Related]
37. Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle.
Chiao PJ; Hunt KK; Grau AM; Abramian A; Fleming J; Zhang W; Breslin T; Abbruzzese JL; Evans DB
Ann N Y Acad Sci; 1999 Jun; 880():31-7. PubMed ID: 10415848
[TBL] [Abstract][Full Text] [Related]
38. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma.
Kim SK; Fan Y; Papadimitrakopoulou V; Clayman G; Hittelman WN; Hong WK; Lotan R; Mao L
Cancer Res; 1996 Jun; 56(11):2519-21. PubMed ID: 8653689
[TBL] [Abstract][Full Text] [Related]
39. Analysis of SMAD4/DPC4 gene alterations in multiploid colorectal carcinomas.
Ando T; Sugai T; Habano W; Jiao YF; Suzuki K
J Gastroenterol; 2005 Jul; 40(7):708-15. PubMed ID: 16082587
[TBL] [Abstract][Full Text] [Related]
40. Inactivation of Smad4 in gastric carcinomas.
Powell SM; Harper JC; Hamilton SR; Robinson CR; Cummings OW
Cancer Res; 1997 Oct; 57(19):4221-4. PubMed ID: 9331080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
